**Facebook****Email**Print**Facebook****Email

Updated April 5, 2024

The U.S. Department of Health and Human Services (HHS), including National Institutes of Health (NIH), operates under the “Extension of Continuing Appropriations and Other Matters Act, 2024” (H.R.7463) signed by President Biden on March 1, 2024.  This Act (CR) continues government operations through March 22, 2024, at the Fiscal Year (FY) 2023 enacted level.  

See our FY 2024 Funding Polices page and Director’s Letter for details about how NIAMS will prioritize funding applications. 

## **Noncompeting RPGs**

Consistent with NIH policy, noncompeting continuation awards will be funded at a level below that indicated on the most recent Notice of Award (90% of the committed level). Upward adjustments to awarded levels will be considered after FY 2024 appropriations are enacted. Please refer to the NIH Notice: NIH Operates Under a Continuing Resolution.

## **Competing RPGs**

                      - Competing R01 applications will be paid through the percentile of 8.0.
                      - Competing R01 applications from early-stage investigators will be paid through the percentile of 15.0.
                      - Competing R21 applications will be paid through the percentile of 8.0.
                      - Competing R15 applications will be paid through the interim payline percentile of 11.0. 
                      - Competing R03 applications will be paid through the interim payline priority score of 15.  
                      - Reductions from direct costs recommended will be approximately 12 percent. No reductions will be taken on applications with direct costs of $100,000 or less.
                      - Rarely, NIAMS receives an application that is within the Institute's payline but is deemed to be of low program priority. In such instances, these cases are discussed in depth with members of the Council before the Institute Director makes a final funding decision. An application can be considered low priority for many reasons, including (but not limited to) redundancy with other projects, concerns about the ultimate relevance of the proposed study's results, or a lack of scientific premise.

## SBIR/STTR

                      - The payline for SBIR applications is pending at this time. 
                      - The payline for STTR applications is pending at this time.

## Research Career Awards

                      - Competing K01/K08/K25 applications will be paid through the payline priority score 30.
                      - Competing K23/24 applications will be paid through the payline priority score 30.
                      - Competing K99 applications will be paid through the payline priority score 30.

## Research Training

                      - Competing research training fellowships (F31, F32, and F33) will be paid through the interim payline percentile of 18.0. 
                      - The payline for competing research training fellowships (F30) is pending at this time. 
                      - Competing institutional training applications (T32) will be paid through the priority score 32.

## Related Announcements

All legislative mandates that were in effect in FY 2023 (see NOT-OD-23-072) remain in effect under the Continuing Resolution.
                      - Notice of Legislative Mandates in Effect for FY 2023                         - Notice of Fiscal Policies in Effect for FY 2023
                        - Guidance on Salary Limitation for Grants and Cooperative Agreements FY 2024
                        - Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels Effective for FY 2023
                        - NIAMS Large Grant Policy for Applications

 

##  

NIAMS Funding Policies

Director's Letter on New Funding Approach

How NIAMS Makes Grant Funding Decisions

April 2024

Back to Top